Notes: PF-06649751 is a dopamine D1 and D5 receptor partial agonist.{57569} It increases locomotor activity and reduces a global parkinsonian disability score in a macaque model of Parkinson’s disease induced by MPTP when administered at a dose of 0.04 mg/kg.